1-4 of 4
Julie Kan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluation of the Antitumor Effects and Mechanisms of PF00299804, a Pan-HER Inhibitor, Alone or in Combination with Chemotherapy or Targeted Agents in Gastric Cancer

Hyun-Jin Nam, Keith A. Ching, Julie Kan, Hwang-Phill Kim, Sae-Won Han, Seock-Ah Im, Tae-You Kim, James G. Christensen, Do-Youn Oh, Yung-Jue Bang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (2): 439–451.
https://doi.org/10.1158/1535-7163.MCT-11-0494
Published: 08 February 2012
View article titled, Evaluation of the Antitumor Effects and Mechanisms of PF00299804, a Pan-HER Inhibitor, Alone or in Combination with Chemotherapy or Targeted Agents in Gastric Cancer
Open the PDF for Evaluation of the Antitumor Effects and Mechanisms of PF00299804, a Pan-HER Inhibitor, Alone or in Combination with Chemotherapy or Targeted Agents in Gastric Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract B103: HSP90 inhibition targets the dysregulated signal and transcription factor network and malignant phenotype of head and neck squamous cell carcinoma.

Christopher J. Gouveia, Stephanie Wise, Jay Friedman, Michael Hu, Christian Freudlsperger, Vishnu Kannabiran, Pattatheyil Arun, James Mitchell, Julie Kan, Nicolleta Brega, Zhong Chen, Carter Van Waes
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): B103.
https://doi.org/10.1158/1535-7163.TARG-11-B103
Published: 12 November 2011
View article titled, Abstract B103: HSP90 inhibition targets the dysregulated signal and transcription factor network and malignant phenotype of head and neck squamous cell carcinoma.
Journal Articles

Abstract A248: Therapeutic effects of the dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor PF-04691502 on in vitro and in vivo models of head and neck squamous cell carcinoma.

Amanda Herzog, Yansong Bian, Bradford Hall, Jamie Coupar, Julie Kan, Zhong Chen, Ashok B. Kulkarni, Carter VanWaes
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): A248.
https://doi.org/10.1158/1535-7163.TARG-11-A248
Published: 12 November 2011
View article titled, Abstract A248: Therapeutic effects of the dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor PF-04691502 on in vitro and in vivo models of head and neck squamous cell carcinoma.
Journal Articles

Knockdown of Ron kinase inhibits activation of mutant PI3 kinase and reduces metastasis in an orthotopic model of human colon carcinoma cells

Ashwani Rajput, Jing Wang, Julie Kan, Rebecca Rose, Karen Kuropatwinski, Jennie Hauser, Alexander Beko, Ivan Dominquez, Elizabeth Sharratt, Charles LeVea, Feng-Lei Sun, David Keane, Neil Gibson, Michael Brattain
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): C33.
Published: 01 November 2007
View article titled, Knockdown of Ron kinase inhibits activation of mutant PI3 kinase and reduces metastasis in an orthotopic model of human colon carcinoma cells